Новости | Магазин | Журналы | Контакты | Правила | Доставка | |
Вход Регистрация |
Ключевые слова:
Литература:
1. Rutka JT, Hoffman HJ. Medulloblastoma: a historical perspective
and overview. J Neurooncol. 1996;29(1):17.
2. Hoffman KE, Yock TI. Radiation therapy for pediatric central nervous system tumors. J Child Neurol. 2009;24(11):13871396.
3. Schneider HJ, Rovere S, Corneli G et al. Endocrine dysfunction in
patients operated on for nonpituitaryintracranial tumors. Eur
J Endocrinol. 2006;15:559566.
4. Brada M, Ashley S, Ford D et al. Cerebrovascular mortality in
patients with pituitary adenoma. Clin Endocrinol. 2002;5: 713717.
5. Tomlinson JW, Holden N, Hills RK et al. Association between premature mortality and hypopituitarism. West Midlands Prospective
Hypopituitary Study Group. Lancet. 2001;357:425431.
6. Gleeson HK, Shalet SM. The impact of cancer therapy on the
endocrine system in survivors of childhood brain tumours.
EndocrineRelated Cancer. 2004;11:589602.
7. Withers HR. Biology of radiation oncology; in Tobias JS, Thomas
PRM (eds): Current Radiation Oncology. London, Edward
Arnold, 1994;1:523.
8. Pai HH, Thornton A, Katznelson L et al. Hypothalamic pituitary
function following highdose conformal radiotherapy to the base of
skull: demonstration of a doseeffect relationship using dosevolume
histogram analysis. J Radiat Oncol Biol Phys. 2001; 49:10791092.
9. Samaan NA, Vieto R, Schultz PN et al. Hypothalamic, pituitary and
thyroid dysfunction after radiotherapy to the head and neck. Int
J Radiat Oncol Biol Phys. 1982;8:18571867.
10. Chen MS, Lin FJ, Huang MJ et al. Prospective hormone study of
hypothalamicpituitary function in patients with nasopharyngeal
carcinoma after high dose irradiation. Jpn J Clin Oncol.
1989;19:265270.
11. Hochberg Z, Kuten A, Hertz P et al. The effect of singledose radiation on cell survival and growth hormone secretion by rat anterior
pituitary cells. Radiat Res. 1983;94:508512.
12. Constine LS, Woolf PD, Cann D et al. Hypothal amicpituitary dysfunction after radiation for brain tumors. N Engl J Med. 1993;
328:8794.
13. Clayton PE, Shalet SM. Dose dependency of time of onset of radiationinduced growth hormone deficiency. J Pediatr. 1991;118:
226228.
14. Littley MD, Shalet SM, Beardwell CG et al. Radiationinduced
hypopituitarism is dosedependent. Clin Endocrinol Oxf. 1989;
31:363373.
15. Lam KS, Tse VK, Wang C et al. Effects of cranial irradiation on
hypothalamicpituitary function – a 5year longitudinal study in
patients with nasopharyngeal carcinoma. Q J Med. 1991;78:
165176.
16. Duffner PK, Cohen ME, Voorhess ML et al. Longterm effects of
cranial irradiation on endocrine function in children with brain
tumors. A prospective study. Cancer. 1985;56:21892193.
17. Endocrinopathy after childhood cancer treatment / volume editors, W.H.B. Wallace, C.J.H. Kelnarp.; cm. – (Endocrine development, ISSN 14217082; v. 15)
18. Schmiegelow M, Lassen S, Poulsen HS et al. Cranial radiotherapy of
childhood brain tumours: growth hormonedeficiency and its relation to the biological effective dose of irradiation in a large population based study. J Clin Endocrinol. 2000;53:191197.
19. Ogilvy&Stuart AL, Clark DJ, Wallace WH et al. Endocrine deficit
after fractionated total body irradiation. Arch Dis Child. 1992;
67:11071110.
20. Littley MD, Shalet SM, Morgenstern GR, Deakin DP. Endocrine
and reproductive dysfunction following fractionated total body
irradiation in adults. Q J Med. 1991;78:265274.
21. Brauner R, Czernichow P, Rappaport R. Greater susceptibility to
hypothalamopituitary irradiation in younger children with acute
lymphoblastic leukemia. J Pediatr. 1986;108:332.
22. Agha A, Sherlock M, Brennan S et al. Hypothalamicpituitary dysfunction after irradiation of nonpituitary brain tumors in adults. J
Clin Endocrinol Metab. 2005;90:63556360.
23. Lam KSL, Tse VKS, Wang C et al. Early effects of cranial irradiation on hypothalamicpituitary function. J Clin Endocrinol
Metab. 1987;64:418424.
24. Littley MD, Shalet SM, Beardwell CG et al. Radiation and hypothalamicpituitary function. Baillieres Clin Endocrinol Metab.
1990;4:147175.
25. Clayton PE, Cowel CT. Safety issues in children and adolescents
during growth hormone therapy – a review. Growth Horm IGF
Res. 2000;10(6):306317.
26. Shalet SM, Beardwell CG, Morris Jones PH et al. Growth hormone
deficiency after treatment of acute leukemia in children. Arch Dis
Child. 1976;51:489494.
27. Littley MD, Shalet SM, Beardwell CG et al. Hypopituitarism following external radiotherapy for pituitary tumours in adults.
Q J Med.1989;262:145160.
28. Laughton SJ, Merchant TE, Sklar CA et al. Endocrine outcomes for
children with embryonal brain tumors after riskadapted craniospinal and conformal primarysite irradiation and highdose
chemotherapy with stemcell rescue on the SJMB96 trial. J Clin
Oncol. 2008;26(7):11121118.
29. Toogood AA. Endocrine consequences of brain irradiation. Growth.
Hormone and IGF Research. 2004;14(Suppl A):S118S124.
30. Chieng PU, Huang TS, Chang CC et al. Reduced hypothalamic
blood flow after radiation treatment of nasopharyngealcancer:
SPECT studies in 34 patients. Am J Neuroradiol. 1991;12:661665.
31. Belka C, Budach W, Kortmann RD, Bamberg M. Radiation
induced CNS toxicity – molecular and cellular mechanisms. Br J
Cancer. 2001;85:12331239.
32. Dewey WC, Bedford JS. Radiobiologic principles. In Textbook of
Radiation Oncology. Eds SA Leibel & TL Phillips. Philadelphia:
WB Saunders &Company, 1998;325.
33. Tofilon PJ, Fike JR. The radioresponse of the central nervous sys
tem: a dynamic process. Radiation Research. 2000;153:357370.
34. Spoudeas HA, Hindmarsh PC, Matthews DR et al. Evolution of
growth hormone neurosecretory disturbance after cranial irradiation for childhood brain tumours: a prospective study. J
Endocrinol.1996;150(2):329342.
35. Nishioka H, Ito H, Haraoka J, Hirano A. Histologicalchanges in the
hypofunctional pituitary gland following conventional radiotherapy for adenoma. Histopathology. 2001;38:561566.
36. Rush S, Cooper PR. Symptom resolution, tumor control, and side
effects following postoperative radiotherapy for pituitary macroadenomas. Int J Radiat Oncol Biol Phys. 1997;37:10311034.
37. Arlt W. HUMBea. Frequent and frequently overlooked: treatment
induced endocrine dysfunction in adult longterm survivors of primary brain tumors. Neurology. 1997;49:498506.
38. Goldman S, Turner CD. Late effects of treatment for brain tumors.
Springer, 2009. ISBN 9780387771021.
39. Wallace WHB, Kelnar CJH (eds). Endocrinopathy after Childhood
Cancer Treatment. Endocr Dev. Basel, Karger. 2009;15:124.
40. Мазеркина НА. Эндокринные нарушения после комплексного лечения злокачественных опухолей хиазмальноселлярной области и задней черепной ямки: дисс. ... дра мед. наук.
Москва, 2007.
41. Hulshof MC, Schimmel EC, Bosch DA et al. Hypofractionation in
glioblastoma multiforme. Radiotherapy and Oncology. 2000;54(2):
143148.
42. Измайлов ТР, Паньшин ГА, Даценко ПВ. Роль функционального состояния и классов RPA в выборе режима фракционирования при лечении глиом высокой степени злокачественности. Вопросы онкологии. 2012;58(3):369373.
Keywords: